Pramiconazole
 | |
| Systematic (IUPAC) name | |
|---|---|
| 1-{4-[4-(4-{[(2R,4S)-2-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-3-isopropylimidazolidin-2-one | |
| Clinical data | |
| Identifiers | |
 | |
| None | |
| PubChem | CID 11411233 |
| UNII |
4SYH0R661F  |
| ChEMBL |
CHEMBL175797 |
| Chemical data | |
| Formula | C35H39F2N7O4 |
| 659.725 g/mol | |
| (what is this?) (verify) | |
Pramiconazole is a triazole antifungal undergoing research for the treatment of acute skin and mucosal fungal infections.
It is developed by Barrier Therapeutics.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||